New Product Pairing Enhances Pathologists’ Ability To Confirm Diagnoses And Improve Productivity

Elsevier, the leading publisher of health science information products and services, announced today that it has entered into an agreement to offer its PathConsult online diagnosis resource tool through mTuitive’s xPert for Pathology™ system, bundling two powerful knowledge- and technology-based products. The agreement empowers pathologists to maximize the accuracy and efficiency of their diagnoses by providing access to the advanced information resources of PathConsult to xPert for Pathology™ users.

“The addition of PathConsult is a great enhancement to xPert for Pathology and we are proud to be associated with this first-class international publishing firm,” states John Murphy, CEO of mTuitive. “PathConsult contains tremendous context sensitive resources that enhances the knowledge xPert for Pathology aims to deliver to pathologists when they need it.”

mTuitive’s xPert for Pathology™ is an interactive software product for quickly and easily reporting malignant tumors according to the College of American Pathologists’ protocols. The product provides expert guidance, error checks and complete documentation, with the aim of standardizing practice and providing knowledge to the practitioner at critical decision times. PathConsult is an Elsevier clinical decision support tool that provides the latest clinical content, along with thousands of images, in an online resource allowing professionals to quickly get the diagnostic information they need, exactly when they need it.

“This agreement reflects Elsevier’s commitment to deliver a truly innovative tool for customers and end-users,” said Randy Charles, Executive Vice President, Clinical Solutions, for Elsevier. “It is a reflection of the commitment and dedication that the two organizations have to develop the latest workflow tools for improving the quality and effectiveness of healthcare delivery.”